AP
TDOC icon

Adero Partners’s Teladoc Health TDOC Stock Holding History

Adero Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,299
Closed -$293K – 166
2022
Q2 		$293K Sell
7,299
-48
-0.7% -$2.04K 0.04% 120
2022
Q1 		$530K Buy
7,347
+108
+1% +$7.78K 0.08% 86
2021
Q4 		$665K Hold
7,239
– – 0.11% 79
2021
Q3 		$918K Hold
7,239
– – 0.17% 61
2021
Q2 		$1.2M Buy
7,239
+3
+0% +$486 0.28% 43
2021
Q1 		$1.31M Sell
7,236
-10
-0.1% -$2.32K 0.59% 33
2020
Q4 		$1.45M Buy
+7,246
New +$1.47M 1.24% 16

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Adero Partners's TDOC Position: Q3 2022 in Review

Adero Partners sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 7,299 shares — an estimated $293K sold.

Adero Partners first reported a position in TDOC in Q4 2020 and held it in 7 quarters. The position peaked at $1.45M in Q4 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Adero Partners reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Adero Partners sold 7,299 Teladoc Health shares in Q3 2022, an estimated $293K.
  • Adero Partners first reported a position in Teladoc Health in Q4 2020 and held it in 7 quarters.
  • Adero Partners's Teladoc Health position peaked at $1.45M in Q4 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Adero Partners's 13F filing for Q3 2022, filed 25 Oct 2022.